Quasi drugs production value in Japan 2014-2023
In 2023, the value of quasi-drugs produced in Japan amounted to around 1.42 trillion Japanese yen. The figure increased compared to around 923 billion yen in 2014.
Advertisement
Advertisement
Production value of quasi-drugs in Japan from 2014 to 2023 (in billion Japanese yen)
* For commercial use only
Basic Account
For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
- Free Statistics
Based on your interests
Starter Account
For single users
$199 USD
per month, billed annually
1
- Free Statistics
- Premium Statistics
The statistic on this page is a Premium Statistic and is included in this account.
Professional Account
For teams of up to 5 people
$1,299 USD
per month, billed annually
1
- Free + Premium Statistics
- Reports
- Market Insights
1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.
Other statistics that may interest you Medication and medical treatments in Japan
Overview
6
- Premium Statistic Production value of pharmaceutical drugs Japan 2014-2023
- Premium Statistic Production value of medical drugs Japan 2021, by production place
- Premium Statistic Production value of pharmaceuticals Japan 2023, by prefecture
- Premium Statistic Number of medical drug manufacturing plants Japan 2023, by production value
- Premium Statistic Leading pharmaceutical companies Japan 2023, by R&D costs
- Premium Statistic Opinion on what drugs should be covered by public health insurance Japan 2023
Production value of medication
6
- Premium Statistic Production value of drugs Japan 2023, by category
- Premium Statistic Production value of oncology drugs Japan 2019-2021
- Premium Statistic Production value of metabolic drugs Japan 2019-2022
- Premium Statistic Production value of central nervous system drugs Japan 2019-2022
- Premium Statistic Production value of cardiovascular agents Japan 2019-2023
- Premium Statistic Production value of drugs for blood and body fluids Japan 2019-2022
Production value of medication by category
5
- Premium Statistic Production value of oncology drugs Japan 2021, by type
- Premium Statistic Production value of metabolic drugs Japan 2022, by type
- Premium Statistic Production value of central nervous system drugs Japan 2022, by type
- Premium Statistic Production value of cardiovascular agents Japan 2023, by type
- Premium Statistic Production value of drugs for blood and body fluids Japan 2022, by type
OTC and prescription drugs
7
- Premium Statistic Prescription drug market size Japan 2003-2024
- Premium Statistic Production value of prescription drugs Japan 2014-2023
- Premium Statistic Sales value of major prescription drugs Japan 2024
- Premium Statistic Share of prescription drug sales Japan FY 2014-2023, by channel
- Premium Statistic Share of prescription and OTC drug in wholesale Japan FY 2013-2022
- Premium Statistic Wholesale value of OTC drugs Japan FY 1990-2022
- Premium Statistic Number of BTC and OTC drugs approved by PMDA Japan FY 2014-2023
Quasi drugs
4
- Premium Statistic Quasi drugs production value in Japan 2014-2023
- Premium Statistic Quasi drugs production value in Japan 2023, by therapeutic category
- Premium Statistic Production value of medicated cosmetics Japan 2023, by category
- Premium Statistic Production value of hair remedies Japan 2023, by category
Health supplements
5
- Premium Statistic Health foods market size in Japan FY 2016-2025
- Premium Statistic Dietary supplements market size in Japan 2019-2025
- Premium Statistic Purchase channels for dietary and health supplements Japan 2024
- Premium Statistic Share of people who consumed dietary supplements in Japan 2024
- Premium Statistic Frequency of taking dietary supplements in Japan 2024
Alternative medicine
5
- Premium Statistic Market size of alternative medicine treatments in Japan 2014-2023
- Premium Statistic Number of acupuncturists Japan 2006-2022
- Premium Statistic Number of moxibustion practitioners Japan 2006-2022
- Premium Statistic Number of judo therapists Japan 2006-2022
- Premium Statistic Number of shiatsu and anma massages treatment centers Japan 2006-2022
Further related statistics
9
- Pfizer ad spending 2006-2024
- Cost savings through urgent care vs emergency department 2012
- Unitedhealth Group total assets 2020 to 2024
- Medicaid long-term care expenditures in the U.S. 1990-2022,by type of service
- Top 10 most expensive conditions treated in the U.S. - hospitals stays 2017
- Medicinal market growth worldwide including rebates 2009-2018
- Mental health and substance abuse services industry revenues in the U.S. 2008-2018
- Standard Unit medicine use per capita in the U.S. 2007-2011
- Biotech company distribution by geographical location
Further Content: You might find this interesting as well
Statistics
- Pfizer ad spending 2006-2024
- Cost savings through urgent care vs emergency department 2012
- Unitedhealth Group total assets 2020 to 2024
- Medicaid long-term care expenditures in the U.S. 1990-2022,by type of service
- Top 10 most expensive conditions treated in the U.S. - hospitals stays 2017
- Medicinal market growth worldwide including rebates 2009-2018
- Mental health and substance abuse services industry revenues in the U.S. 2008-2018
- Standard Unit medicine use per capita in the U.S. 2007-2011
- Biotech company distribution by geographical location
* For commercial use only
Basic Account
For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
- Free Statistics
Based on your interests
Starter Account
For single users
$199 USD
per month, billed annually
1
- Free Statistics
- Premium Statistics
The statistic on this page is a Premium Statistic and is included in this account.
Professional Account
For teams of up to 5 people
$1,299 USD
per month, billed annually
1
- Free + Premium Statistics
- Reports
- Market Insights
1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.
MHLW (Japan). (December 25, 2024). Production value of quasi-drugs in Japan from 2014 to 2023 (in billion Japanese yen) [Graph]. In Statista. Retrieved June 13, 2025, from https://www.statista.com/statistics/820996/japan-quasi-drug-production-value/
MHLW (Japan). "Production value of quasi-drugs in Japan from 2014 to 2023 (in billion Japanese yen)." Chart. December 25, 2024. Statista. Accessed June 13, 2025. https://www.statista.com/statistics/820996/japan-quasi-drug-production-value/
MHLW (Japan). (2024). Production value of quasi-drugs in Japan from 2014 to 2023 (in billion Japanese yen). Statista. Statista Inc.. Accessed: June 13, 2025. https://www.statista.com/statistics/820996/japan-quasi-drug-production-value/
MHLW (Japan). "Production Value of Quasi-drugs in Japan from 2014 to 2023 (in Billion Japanese Yen)." Statista, Statista Inc., 25 Dec 2024, https://www.statista.com/statistics/820996/japan-quasi-drug-production-value/
MHLW (Japan), Production value of quasi-drugs in Japan from 2014 to 2023 (in billion Japanese yen) Statista, https://www.statista.com/statistics/820996/japan-quasi-drug-production-value/ (last visited June 13, 2025)
Production value of quasi-drugs in Japan from 2014 to 2023 (in billion Japanese yen) [Graph], MHLW (Japan), December 25, 2024. [Online]. Available: https://www.statista.com/statistics/820996/japan-quasi-drug-production-value/
Advertisement